Published in J Clin Microbiol on February 28, 2007
Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010. J Virol (2013) 1.03
Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. J Clin Microbiol (2008) 1.02
Phylogenetic and evolutionary history of influenza B viruses, which caused a large epidemic in 2011-2012, Taiwan. PLoS One (2012) 0.98
Genetic analysis of influenza B viruses isolated in Uganda during the 2009-2010 seasons. Virol J (2013) 0.92
Ten years (2004-2014) of influenza surveillance in Northern Italy. Hum Vaccin Immunother (2014) 0.81
Surveillance of influenza viruses in the post-pandemic era (2010-2012) in Northern Italy. Hum Vaccin Immunother (2013) 0.80
Whole-genome analysis of influenza B viruses of multiple genotypes cocirculating in India. Genome Announc (2013) 0.80
Virological investigation of four outbreaks of influenza B reassortants in the northern region of Taiwan from October 2006 to February 2007. BMC Res Notes (2009) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet (2000) 69.26
TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57
The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci (2001) 4.74
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology (1990) 4.71
DNASTAR's Lasergene sequence analysis software. Methods Mol Biol (2000) 4.52
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Phylogenetic analysis using PHYLIP. Methods Mol Biol (2000) 3.27
Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol (2004) 1.83
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology (2002) 1.57
Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005. J Clin Microbiol (2006) 1.15
Bioinformatics in protein analysis. EXS (2000) 1.07
Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis (2006) 3.51
Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics (2002) 2.94
Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc (2009) 2.28
Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA (2004) 2.20
Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology (2012) 1.97
The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis (2002) 1.90
Neural pathogenesis of enterovirus 71 infection. Microbes Infect (2010) 1.66
Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect (2011) 1.64
Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52
Genomic signatures of influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 1.48
hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol (2009) 1.41
The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology (2002) 1.40
Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5' untranslated region and participates in virus replication. J Gen Virol (2008) 1.39
Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog (2009) 1.36
Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta (2003) 1.34
Influenza A virus PB1-F2 gene in recent Taiwanese isolates. Emerg Infect Dis (2004) 1.29
Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol (2005) 1.26
Viral and host proteins involved in picornavirus life cycle. J Biomed Sci (2009) 1.24
Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem (2009) 1.23
An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J (2010) 1.22
Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res (2008) 1.20
Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Res (2008) 1.19
Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand J Infect Dis (2002) 1.19
Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine (2002) 1.18
Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol (2010) 1.17
HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics (2008) 1.15
Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta (2002) 1.14
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol (2004) 1.13
Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J Clin Microbiol (2006) 1.12
Molecular evolution and the global reemergence of enterovirus D68 by genome-wide analysis. Medicine (Baltimore) (2016) 1.11
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem (2008) 1.10
Systematic phylogenetic analysis of influenza A virus reveals many novel mosaic genome segments. Infect Genet Evol (2013) 1.09
Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol (2012) 1.09
Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J Med Chem (2002) 1.08
Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children's hospital experience. J Microbiol Immunol Infect (2010) 1.07
Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J Med Virol (2012) 1.06
Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09. PLoS Negl Trop Dis (2012) 1.06
Comparative genomic analysis of coxsackievirus A6 strains of different clinical disease entities. PLoS One (2012) 1.05
Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions. J Infect Dis (2013) 1.04
Update on the development of enterovirus 71 vaccines. Expert Opin Biol Ther (2014) 1.02
Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. J Clin Microbiol (2008) 1.02
Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan. J Clin Virol (2008) 1.02
Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth. Nucleic Acids Res (2011) 1.00
Identification of genes involved in the host response to enterovirus 71 infection. J Neurovirol (2004) 1.00
Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis (2011) 1.00
Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol (2008) 1.00
Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother (2010) 0.98
Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol (2006) 0.97
Epidemiologic features and virus isolation of enteroviruses in Northern Taiwan during 2000-2008. J Virol Methods (2010) 0.97
Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors. Bioorg Med Chem Lett (2004) 0.97
MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One (2013) 0.97
Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives. J Med Chem (2010) 0.96
Molecular epidemiology and clinical manifestations of viral gastroenteritis in hospitalized pediatric patients in Northern Taiwan. J Clin Microbiol (2007) 0.96
A panel of multiple markers associated with chronic systemic inflammation and the risk of atherogenesis is detectable in asthma and chronic obstructive pulmonary disease. J Clin Lab Anal (2007) 0.94
Serotype-specific detection of enterovirus 71 in clinical specimens by DNA microchip array. J Virol Methods (2003) 0.94
Development of antiviral agents for enteroviruses. J Antimicrob Chemother (2008) 0.94
Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J (2003) 0.93
Strategies to develop antivirals against enterovirus 71. Virol J (2013) 0.92
Polarized photoluminescence from single GaN nanorods: effects of optical confinement. Opt Express (2008) 0.92
Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives. J Med Chem (2005) 0.91
Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob Agents Chemother (2009) 0.91
Cell-free DNA is released from tumor cells upon cell death: a study of tissue cultures of tumor cell lines. J Clin Lab Anal (2003) 0.90
Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker. Ann Clin Lab Sci (2006) 0.90
Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J Infect Dis (2008) 0.89
The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases. Curr Med Chem (2007) 0.88
Responses of IgM for enterovirus 71 infection. J Med Virol (2002) 0.88
Antiviral drug discovery targeting to viral proteases. Curr Pharm Des (2006) 0.88
Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes. J Clin Virol (2013) 0.88
Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS One (2011) 0.88
p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy. Cancer Lett (2004) 0.88
Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerg Infect Dis (2011) 0.88
Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. J Biol Chem (2011) 0.88
Comparing molecular methods for early detection and serotyping of enteroviruses in throat swabs of pediatric patients. PLoS One (2012) 0.87
Clinical features of radiologically confirmed pneumonia due to adenovirus in children. J Clin Virol (2012) 0.86
High-efficiency protein expression mediated by enterovirus 71 internal ribosome entry site. Biotechnol Bioeng (2005) 0.86
Elevated serum chromogranin A precedes prostate-specific antigen elevation and predicts failure of androgen deprivation therapy in patients with advanced prostate cancer. J Formos Med Assoc (2003) 0.86
A novel cis-AB allele derived from the A transferase gene by nucleotide substitution C796A. Ann Clin Lab Sci (2004) 0.86
Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Oral Oncol (2008) 0.85
Heat shock protein-90-beta facilitates enterovirus 71 viral particles assembly. Virology (2013) 0.85